Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mutsumi Hayashi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Blood Cancer Journal|October 24, 2018
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myelomaHiroko Nishida, Mutsumi Hayashi, Chikao Morimoto, et al.
Cancer Science|May 10, 2019
Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cellsMasako Imaoka, Keiji Tanese, Yohei Masugi, et al.
Cancer Research Communications|January 29, 2024
HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter ActivationHiroko Nishida, Reiko Suzuki, Kiyora Nakajima, et al.
Surgical Case Reports|March 9, 2026
Radiation-Induced Angiosarcoma Following Breast Surgery: A Case ReportMutsumi Hayashi, Yukino Kobayashi, Ryoko Semba, et al.
Cancer Cell International|June 27, 2009
Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effectKohji Yamada, Mutsumi Hayashi, Wenlin Du, et al.
Cancer Cell International|May 3, 2016
A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transitionMutsumi Hayashi, Hiroko Madokoro, Koji Yamada, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 14, 2014
Blockade of CD26 signaling inhibits human osteoclast developmentHiroko Nishida, Hiroshi Suzuki, Hiroko Madokoro, et al.
Cancers|August 11, 2019
Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA SynthesisMutsumi Hayashi, Hiroko Madokoro, Koji Yamada, et al.
British Journal of Haematology|April 6, 2007
Establishment of a novel childhood acute myeloid leukaemia cell line, KOPM-88, containing partial tandem duplication of the MLL gene and an in vivo model for childhood acute myeloid leukaemia using NOD/SCID miceMutsumi Hayashi, Kensuke Kondoh, Yuji Nakata, et al.
International Immunology|August 12, 2008
Altered cellular immunity in transgenic mice with T cell-specific expression of human D4-guanine diphosphate-dissociation inhibitor (D4-GDI)Kensuke Kondoh, Yuji Nakata, Takashi Yamaoka, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood Cancer Journal|October 24, 2018
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myelomaHiroko Nishida, Mutsumi Hayashi, Chikao Morimoto, et al.
Cancer Science|May 10, 2019
Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cellsMasako Imaoka, Keiji Tanese, Yohei Masugi, et al.
Cancer Research Communications|January 29, 2024
HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter ActivationHiroko Nishida, Reiko Suzuki, Kiyora Nakajima, et al.
Surgical Case Reports|March 9, 2026
Radiation-Induced Angiosarcoma Following Breast Surgery: A Case ReportMutsumi Hayashi, Yukino Kobayashi, Ryoko Semba, et al.
Cancer Cell International|June 27, 2009
Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effectKohji Yamada, Mutsumi Hayashi, Wenlin Du, et al.
Cancer Cell International|May 3, 2016
A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transitionMutsumi Hayashi, Hiroko Madokoro, Koji Yamada, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 14, 2014
Blockade of CD26 signaling inhibits human osteoclast developmentHiroko Nishida, Hiroshi Suzuki, Hiroko Madokoro, et al.
Cancers|August 11, 2019
Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA SynthesisMutsumi Hayashi, Hiroko Madokoro, Koji Yamada, et al.
British Journal of Haematology|April 6, 2007
Establishment of a novel childhood acute myeloid leukaemia cell line, KOPM-88, containing partial tandem duplication of the MLL gene and an in vivo model for childhood acute myeloid leukaemia using NOD/SCID miceMutsumi Hayashi, Kensuke Kondoh, Yuji Nakata, et al.
International Immunology|August 12, 2008
Altered cellular immunity in transgenic mice with T cell-specific expression of human D4-guanine diphosphate-dissociation inhibitor (D4-GDI)Kensuke Kondoh, Yuji Nakata, Takashi Yamaoka, et al.
Pageof 2